Search

everythinglearnresearchcommunity

for

Search:↓

KAP8.1 protein is crucial for hair structure and interacts with keratin 85.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

PRPF is a safer and more effective treatment for hair loss than PRP.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

Blocking certain proteins in mouse skin can reduce and shrink skin tumors.

Three specific mutations in the LIPH gene can cause hair loss by damaging the protein's structure and function.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Retinol with polylysine cleared scalp skin growths in 21 days without side effects.

A Japanese patient with a rare genetic disorder had a less severe case than others, suggesting other factors may affect symptoms.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Congenital atrichia with papular lesions is often misdiagnosed, and new diagnostic criteria can improve accuracy.

A Pomeranian dog had rickets due to a new gene mutation, leading to severe symptoms and euthanasia.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Phosphates strongly attach to cerium dioxide nanoparticles, showing specific spectral patterns.

A benign skin tumor was removed from a man's leg, and it didn't come back after 9 months.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

ICP5249 helps hair grow by activating a specific cell pathway.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Polarizing light microscopy can easily and reliably diagnose congenital keratinizing disorders like Netherton syndrome.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

PRGF can improve acne and scars.

Some prostate cancers have gene changes that may affect treatment with certain drugs.